Table 4.
White Europeans (n = 29) | Black Africans (n = 19) | p-value | |
---|---|---|---|
Age, mean ± SD | 48.83 ± 20.09 | 31.74 ± 11.82 | 0.0017* |
Flow Citometry median (Q1; Q3) | |||
TL, c (cells/μL) | 1019 (830; 1433) | 803 (602; 1161) | 0.05 |
CD4+, c (cells/μL) | 726 (444; 901) | 472 (369; 536) | 0.009* |
CD4+, % | 45.01 (38.86; 48.14) | 38.71 (33.06; 45.77) | 0.03* |
CD8+, c (cells/μL) | 356 (231; 556) | 337 (182; 522) | 0.45 |
CD8+, % | 26.07 (19.59; 30.18) | 31.63 (24.42; 33.49) | 0.10 |
BL, c (cells/μL) | 145 (68; 209) | 94 (43; 123) | 0.08 |
BL, % | 8.90 (6.40; 12.00) | 7.30 (5.05; 11.85) | 0.41 |
NKL, c (cells/μL) | 199 (131; 298) | 140 (84; 284) | 0.24 |
NKL, % | 13.65 (8.14; 19.05) | 13.73 (7.05; 21.48) | 0.93 |
CD4+/CD8+ | 1.59 (1.31; 2.85) | 1.48 (1.11; 1.85) | 0.12 |
CT pattern | |||
Productive forms | 22 (76%) | 8 (42%) | χ 0.03* |
Exudative forms | 7 (24%) | 11 (57%) | |
Typical | 21 (72%) | 7 (37%) | χ 0.02* |
Atypical | 8 (28%) | 12 (63%) |
TL, total lymphocytes; BL, B-lymphocytes, NKL, natural killer lymphocytes; SD, standard deviation; Q1, first quartile; Q3 third quartile. (χ) Assessed with chi-square test. p < 0.05 is denoted by *.